Nomura Holdings
OSIR

Nomura Holdings’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Nomura Holdings’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-15,674
Closed -$206K – 3320
2014
Q1 		$206K Buy
+15,674
New +$245K ﹤0.01% 2321

Other funds holding OSIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Nomura Holdings's OSIR Position: Q2 2014 in Review

Nomura Holdings sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2014, closing a stake of 15,674 shares — an estimated $206K sold.

Nomura Holdings first reported a position in OSIR in Q1 2014 and held it in 1 quarter. The position peaked at $206K in Q1 2014. 67 funds tracked by Wall St. Rank hold OSIR as of Q2 2014.

  • Nomura Holdings reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2014 after selling out during the quarter.
  • Nomura Holdings sold 15,674 Osiris Therapeutics, Inc. Common Stock shares in Q2 2014, an estimated $206K.
  • Nomura Holdings first reported a position in Osiris Therapeutics, Inc. Common Stock in Q1 2014 and held it in 1 quarter.
  • Nomura Holdings's Osiris Therapeutics, Inc. Common Stock position peaked at $206K in Q1 2014.
  • 67 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2014.

Based on Nomura Holdings's 13F filing for Q2 2014, filed 13 Aug 2014.